Observing the natural history of a rare brain disorder called LBSL
Official title: Characterization of the Natural History of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation
Run by Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · NCT03624374 · Data updated 2026-11-12
This study looks at how a rare brain disorder called LBSL affects movement and thinking in patients to better understand their challenges and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | April 1, 2018 |
| Main results expected | May 2029 |
| Study ends | May 2029 |
| Registry record updated | July 3, 2024 |
| Trial ID | NCT03624374 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals with a confirmed DARS2 mutation and the ability to communicate in English at an 8th-grade level.
✕Probably not a fit
Patients who do not have a confirmed DARS2 mutation or those who cannot communicate in English may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on individuals diagnosed with leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL). It involves retrospective chart and imaging reviews, as well as prospective longitudinal virtual assessments to gather detailed information on the neurocognitive and neuromotor impairments associated with this rare genetic disorder. The study aims to identify the phenotypic spectrum of deficits, particularly in gait, and their impact on the quality of life of patients. Currently, there are no targeted therapies or established guidelines for supportive care in LBSL, making this research crucial for understanding the condition better.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the progression and impact of LBSL, potentially guiding future therapeutic approaches.
How similar studies have gone: While there is limited data on LBSL, similar observational studies in rare genetic disorders have provided valuable insights, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Confirmed DARS2 mutation through genetic analysis 2. Ability of the caregiver or participant to speak and understand English at an 8th-grade level Exclusion Criteria: * The vulnerable populations of prisoners, non-viable neonates, pregnant women, adults lacking the capacity to consent, non-English speakers or children who are in foster care or wards of the state.
Where it's running
-
Hugo Moser Center for Leukodystrophies
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Amena S Fine, MD PhD — Moser Center for Leukodystrophies at Kennedy Krieger Institute
- Study coordinator: Aditii Makwana, MS
- Email: makwana@kennedykrieger.org
- Phone: 667-205-4498
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collecting data and samples from patients with leukodystrophy
This study is collecting health information and samples from people with leukodystrophy to help find new causes and better treatments for the condition.
-
Observing the natural history of patients with HPDL mutations
This study is trying to learn more about people with HPDL mutations and their related mitochondrial diseases by collecting health information and blood samples to see how these conditions change over time.
-
Home exercise program for people with neurodegenerative diseases
This study is testing a home exercise program to see if it can help people with neurodegenerative diseases improve their walking and balance.
-
Natural history and genotype-phenotype patterns in mitochondrial leukoencephalopathies
This study looks at how mitochondrial leukoencephalopathies develop over time and how genetic differences relate to what patients experience.
-
Newborn whole-genome sequencing and genetic disease risk in pregnancy and early life
This project will collect small biological samples from pregnant families and newborns to try whole-genome sequencing and other multi-omics tests to find genetic disease risks.
-
At-home full-body stimulation suit to manage spasticity and ataxia in MS
This project will try whether wearing a full-body electrical stimulation suit for six weeks helps people with MS who have spasticity or ataxia reduce symptoms and improve daily functioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.